Primecap Management CO Gsk PLC Transaction History

Primecap Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$36.52 - $41.46 $288,508 - $327,534	-7,900 Reduced 1.41%	551,400 $22 Million
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $134,400 - $154,400	-3,200 Reduced 0.57%	559,300 $26.3 Million
Q3 2019 Nov 13, 2019	SELL	$40.46 - $43.52 $84,966 - $91,392	-2,100 Reduced 0.37%	562,500 $24 Million
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $484,620 - $525,210	-12,300 Reduced 2.13%	564,600 $22.6 Million
Q4 2018 Feb 12, 2019	SELL	$37.8 - $42.69 $10.1 Million - $11.4 Million	-266,735 Reduced 31.62%	576,900 $22 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $8.1 Million - $8.7 Million	-203,800 Reduced 19.46%	843,635 $33.9 Million
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $908,118 - $1.01 Million	-25,100 Reduced 2.34%	1,047,435 $40.9 Million
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $106,020 - $125,700	-3,000 Reduced 0.28%	1,072,535 $38 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $42.4 Million - $44.7 Million	1,075,535	1,075,535 $43.7 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

Stay updated on Primecap Management CO with notifications on news.